Terns Pharmaceuticals (TERN) Change in Acquisitions & Divestments (2020 - 2023)
Historic Change in Acquisitions & Divestments for Terns Pharmaceuticals (TERN) over the last 4 years, with Q4 2023 value amounting to $52.3 million.
- Terns Pharmaceuticals' Change in Acquisitions & Divestments rose 5610.62% to $52.3 million in Q4 2023 from the same period last year, while for Dec 2023 it was $237.8 million, marking a year-over-year increase of 10201.98%. This contributed to the annual value of $157.6 million for FY2024, which is 3374.96% down from last year.
- According to the latest figures from Q4 2023, Terns Pharmaceuticals' Change in Acquisitions & Divestments is $52.3 million, which was up 5610.62% from $41.8 million recorded in Q3 2023.
- In the past 5 years, Terns Pharmaceuticals' Change in Acquisitions & Divestments ranged from a high of $92.0 million in Q2 2023 and a low of $8.0 million during Q1 2020
- In the last 4 years, Terns Pharmaceuticals' Change in Acquisitions & Divestments had a median value of $30.8 million in 2022 and averaged $34.2 million.
- Per our database at Business Quant, Terns Pharmaceuticals' Change in Acquisitions & Divestments skyrocketed by 1067.65% in 2022 and then surged by 31682.83% in 2023.
- Quarter analysis of 4 years shows Terns Pharmaceuticals' Change in Acquisitions & Divestments stood at $8.0 million in 2020, then soared by 68.92% to $13.5 million in 2021, then surged by 148.14% to $33.5 million in 2022, then skyrocketed by 56.11% to $52.3 million in 2023.
- Its last three reported values are $52.3 million in Q4 2023, $41.8 million for Q3 2023, and $92.0 million during Q2 2023.